characterization of olanzapine – solid dispersions.
Authors
abstract
aim: to enhance the aqueous solubility of olanzapine by using the solid dispersion technique. solid dispersions of olanzapine were prepared by the dispersion method using using pgs and ssg as carriers. drug:carrier ratios such as 1:1, 1:2, 1:4, 1:6, 1:8 and 1:10 were tried for optimization. characterization was done by phase solubility, in vitro release, saturation solubility, permeation, wettability, xrd and ftir analysis. solid dispersions showed higher solubility and an improved drug release profile than the pure drug. solid dispersion and physical mixture with a drug:polymer ratio of 1:10 showed the best release profile in comparison with the other samples. phase solubility results verified the solubilization effect of the carrier. xrd and nir analysis confirmed the reduction of crystallinity in the samples. the release study findings were well supported by the results of wettability, saturation solubility and permeability studies. ir analysis substantiated the inertness of the carrier. it was concluded that pregelatinised starch (pgs) and sodium starch glycollate (ssg) could be utilized as effective carriers to improve the aqueous solubility of poorly soluble drugs.
similar resources
Characterization of Olanzapine – Solid dispersions.
Aim: To enhance the aqueous solubility of olanzapine by using the Solid dispersion technique. Solid dispersions of Olanzapine were prepared by the dispersion method using using PGS and SSG as carriers. Drug:carrier ratios such as 1:1, 1:2, 1:4, 1:6, 1:8 and 1:10 were tried for optimization. Characterization was done by phase solubility, in vitro release, saturation solubility, permeation, wetta...
full textCharacterization of Olanzapine – Solid dispersions.
Aim: To enhance the aqueous solubility of olanzapine by using the Solid dispersion technique. Solid dispersions of Olanzapine were prepared by the dispersion method using using PGS and SSG as carriers. Drug:carrier ratios such as 1:1, 1:2, 1:4, 1:6, 1:8 and 1:10 were tried for optimization. Characterization was done by phase solubility, in vitro release, saturation solubility, permeation, wetta...
full textCharacterization of Olanzapine-Solid Dispersions
AIM To enhance the aqueous solubility of olanzapine by using the Solid dispersion technique. Solid dispersions of olanzapine were prepared by the dispersion method using using PGS and SSG as carriers. Drug-carrier ratios such as 1 : 1, 1 : 2, 1 : 4, 1 : 6, 1: 8 and 1 : 10 were tried for optimization. Characterization was done by phase solubility, in-vitro release, saturation solubility, permeat...
full textPreparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers
Objective(s):Solid dispersion formulation is the most promising strategy to improve oral bioavailability of poorly water soluble drugs. The aim of this study was to compare the effect of polyvinylpyrrolidone K30 (PVP) and poloxamer-188 (PLX) as carrier in solid dispersion formulations of celecoxib (CLX). Materials and Methods: Solid dispersions of CLX:PVP or CLX:PLX were prepared at different r...
full textDesign of Olanzapine/Lutrol Solid Dispersions of Improved Stability and Performances
Eleven solid dispersions containing olanzapine, with carriers of different composition (Lutrol® F68, Lutrol® F127, Gelucire® 44/14), were prepared and examined by thermal (differential scanning calorimetry (DSC); thermomicroscopy (HSM)) and X-ray diffraction (XRD) analysis, both as fresh or aged (one year) samples. Drug and carriers were preliminarily selected in order to avoid problems related...
full textFormulation and Characterization of Solid Dispersions of Glimepiride through Factorial Design
In order to enhance in vitro dissolution and content uniformity of poorly soluble drug glimepiride by preparing solid dispersions using modified solvent fusion method, solid dispersions of drug were prepared by modified fusion solvent method using PEG 6000 and PVP K25 (as carrier). Eight batches (F1-F8) were prepared by Factorial design (23) by taking three ...
full textMy Resources
Save resource for easier access later
Journal title:
the iranian journal of pharmaceutical researchجلد ۲۰۱۱، شماره ۳، صفحات ۱۳-۲۳
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023